Click Therapeutics Secures $20 Million Debt Financing From Hsbc

By Author: Arina Smith
Total Articles: 185
Comment this article

Click Therapeutics, Inc. recently secured a $20 million term loan from HSBC Innovation Banking to support its mission in the digital therapeutics space. The funds were partially utilized to retire a previous term loan, leaving the remaining balance available for furthering the company's prescription digital therapeutic pipeline. This financial boost comes as Click Therapeutics experiences significant growth.

The company is actively engaged in co-development and commercialization collaborations to address major depressive disorder (MDD), schizophrenia, and substance use disorders. Additionally, Click Therapeutics is advancing its internal program for the preventive treatment of migraines, with pivotal data expected in 2024.

Randall Stanicky, Chief Financial Officer of Click Therapeutics, expressed enthusiasm about this partnership with HSBC Innovation Banking and emphasized that the capital infusion will facilitate important investments in the company's platform and therapeutic pipeline.

Click Therapeutics specializes in developing, validating, and commercializing software-based prescription medical treatments ...
... for individuals with unmet medical needs. Their Digital Therapeutics™ platform delivers FDA-regulated prescription treatments directly to smartphones. The company's approach combines technical and scientific rigor with patient-centric design to create engaging, effective clinical outcomes. Click Therapeutics continually expands its platform, incorporating innovative cognitive, behavioral, and neuromodulatory mechanisms, along with advanced data-driven tools like artificial intelligence and machine learning. They address therapeutic needs in various areas, including psychiatry, neurology, oncology, immunology, and cardiometabolic diseases.

HSBC Innovation Banking recognized the potential of partnering with Click Therapeutics and sees this collaboration as a valuable opportunity in the digital therapeutic space. The bank's extensive innovation network and global presence position Click Therapeutics for growth at every stage of its development.

This partnership reflects Click Therapeutics' dedication to advancing digital therapeutics that enhance patient access to safe and effective treatments. It also underscores HSBC's role in supporting innovative companies in the healthcare sector.

For more details about Click Therapeutics, visit their website at [www.clicktherapeutics.com](https://www.clicktherapeutics.com). To learn more about HSBC, please visit [https://www.us.hsbc.com/](https://www.us.hsbc.com/).